LINC00342
gene geneOn this page
Summary
LINC00342 (long intergenic non-protein coding RNA 342, HGNC:42470) is a long non-coding RNA gene on chromosome 2q11.1.
Biomarker of Huntington’s disease.
Source: NCBI Gene 150759 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:42470 |
| Approved symbol | LINC00342 |
| Name | long intergenic non-protein coding RNA 342 |
| Location | 2q11.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000232931 |
| Ensembl biotype | lncRNA |
| Entrez | 150759 |
| RNAcentral | URS000075C528 — lncRNA, 3128 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 16 lncRNA
ENST00000412393, ENST00000448494, ENST00000655069, ENST00000657232, ENST00000659287, ENST00000660416, ENST00000660608, ENST00000660641, ENST00000661329, ENST00000662121, ENST00000663557, ENST00000664191, ENST00000668171, ENST00000824807, ENST00000824808, ENST00000824809
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000412393 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001658085 | 95814671 | 95814776 |
| ENSE00001765590 | 95813316 | 95813533 |
| ENSE00001777715 | 95813909 | 95813957 |
| ENSE00001805647 | 95807118 | 95807302 |
| ENSE00002466369 | 95814050 | 95814145 |
Expression profiles
Bgee: expression breadth ubiquitous, 271 present calls, max score 98.81.
FANTOM5 (CAGE): breadth broad, TPM avg 0.6903 / max 162.8225, expressed in 251 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 29696 | 0.6903 | 251 |
Top tissues by expression
287 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 98.81 | gold quality |
| left testis | UBERON:0004533 | 98.32 | gold quality |
| right testis | UBERON:0004534 | 98.26 | gold quality |
| right uterine tube | UBERON:0001302 | 97.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 97.29 | gold quality |
| sural nerve | UBERON:0015488 | 96.87 | gold quality |
| minor salivary gland | UBERON:0001830 | 96.74 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.31 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.98 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.91 | gold quality |
| testis | UBERON:0000473 | 94.83 | gold quality |
| pylorus | UBERON:0001166 | 93.54 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 93.42 | gold quality |
| left ovary | UBERON:0002119 | 93.39 | gold quality |
| right ovary | UBERON:0002118 | 93.13 | gold quality |
| cerebellum | UBERON:0002037 | 92.80 | gold quality |
| body of pancreas | UBERON:0001150 | 92.25 | gold quality |
| mouth mucosa | UBERON:0003729 | 92.12 | gold quality |
| body of stomach | UBERON:0001161 | 92.00 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.97 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.90 | gold quality |
| nucleus accumbens | UBERON:0001882 | 91.79 | gold quality |
| tibial nerve | UBERON:0001323 | 91.73 | gold quality |
| caudate nucleus | UBERON:0001873 | 91.54 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 91.50 | gold quality |
| stomach | UBERON:0000945 | 91.30 | gold quality |
| body of uterus | UBERON:0009853 | 91.24 | gold quality |
| tendon | UBERON:0000043 | 91.17 | gold quality |
| pituitary gland | UBERON:0000007 | 91.08 | gold quality |
| medial globus pallidus | UBERON:0002477 | 90.90 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.23 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- LINC00342 is involved in the development, and LINC00342 may be a potential diagnostic factor and a target for new therapies for future patients with non-small cell lung cancer. (PMID:30320899)
- Long noncoding RNA LINC00342 promotes growth of infantile hemangioma by sponging miR-3619-5p from HDGF. (PMID:31469292)
- LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p. (PMID:31539128)
- LINC00342 was over-expressed in colon adenocarcinoma (COAD) tissues and was related to the poor prognosis. LINC00342 knockdown inhibited cell proliferation, migration and invasion and promoted apoptosis of COAD cells. LINC00342 targeted to miR-545-5p/ MDM2 in COAD. In COAD tissues and cell lines, LINC00342 expression was positively correlated to MDM2 expression, while it was negatively correlated to miR-545-5p expression. (PMID:32213297)
- LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis. (PMID:34715819)
- LINC00342 induces metastasis of lung adenocarcinoma by targeting miR-15b/TPBG. (PMID:35452205)
- [Biological function and clinical significance of long non-coding RNA LINC00342 in head and neck squamous carcinoma]. (PMID:36878503)
- [LncRNA LINC00342 regulates gastric cancer cell proliferation, migration and invasion by targeting miR-596]. (PMID:37933652)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.